These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10817504

  • 21. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH, Shin MS, Lee HS, Bae JH, Lee HK, Kim HS, Kim SY, Jang JJ, Joo M, Kang YK, Park WS, Park JY, Oh RR, Han SY, Lee JH, Kim SH, Lee JY, Yoo NJ.
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [Abstract] [Full Text] [Related]

  • 22. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Mar; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 23. Soluble Fas (FasB) regulates luteal cell apoptosis during luteolysis in murine ovaries.
    Komatsu K, Manabe N, Kiso M, Shimabe M, Miyamoto H.
    Mol Reprod Dev; 2003 Aug; 65(4):345-52. PubMed ID: 12840807
    [Abstract] [Full Text] [Related]

  • 24. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
    Gormus U, Ergen A, Yilmaz H, Dalan B, Berkman S, Isbir T.
    Anticancer Res; 2007 Aug; 27(2):991-4. PubMed ID: 17465232
    [Abstract] [Full Text] [Related]

  • 25. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium.
    Hamann KJ, Dorscheid DR, Ko FD, Conforti AE, Sperling AI, Rabe KF, White SR.
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749
    [Abstract] [Full Text] [Related]

  • 26. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, Salvioli G, Cossarizza A.
    Circulation; 2004 Nov 09; 110(19):3108-14. PubMed ID: 15505087
    [Abstract] [Full Text] [Related]

  • 27. Human colon cancer cells express the functional Fas ligand.
    Ding EX, Hizuta A, Morimoto Y, Tanida T, Hongo T, Ishii T, Yamano T, Fujiwara T, Iwagaki H, Tanaka N.
    Res Commun Mol Pathol Pharmacol; 1998 Jul 09; 101(1):13-24. PubMed ID: 9755840
    [Abstract] [Full Text] [Related]

  • 28. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.
    Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC, Cheung AN.
    Carcinogenesis; 2009 Jan 09; 30(1):114-21. PubMed ID: 18796737
    [Abstract] [Full Text] [Related]

  • 29. Expression of Fas and Fas ligand in human testicular germ cell tumours.
    Baldini E, Ulisse S, Marchioni E, Di Benedetto A, Giovannetti G, Petrangeli E, Sentinelli S, Donnorso RP, Reale MG, Mottolese M, Gandini L, Lenzi A, D'Armiento M.
    Int J Androl; 2009 Apr 09; 32(2):123-30. PubMed ID: 17916181
    [Abstract] [Full Text] [Related]

  • 30. Detection of Fas ligand in the bovine oviduct.
    Bergqvist AS, Killian G, Erikson D, Hoshino Y, Båge R, Sato E, Rodríguez-Martínez H.
    Anim Reprod Sci; 2005 Mar 09; 86(1-2):71-88. PubMed ID: 15721660
    [Abstract] [Full Text] [Related]

  • 31. Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro.
    Berkkanoglu M, Guzeloglu-Kayisli O, Kayisli UA, Selam BF, Arici A.
    Mol Hum Reprod; 2004 Jun 09; 10(6):393-8. PubMed ID: 15073283
    [Abstract] [Full Text] [Related]

  • 32. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.
    Urology; 2004 Jun 09; 63(6):1198-204. PubMed ID: 15183989
    [Abstract] [Full Text] [Related]

  • 33. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
    Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ.
    Oncogene; 1999 Jun 24; 18(25):3754-60. PubMed ID: 10391683
    [Abstract] [Full Text] [Related]

  • 34. Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma.
    Tsai MH, Chow KC, Lin TY, Yeh SP, Hsueh CT, Chi KH.
    Oncol Rep; 2002 Jun 24; 9(2):247-51. PubMed ID: 11836588
    [Abstract] [Full Text] [Related]

  • 35. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
    Belluco C, Esposito G, Bertorelle R, Alaggio R, Giacomelli L, Bianchi LC, Nitti D, Lise M.
    Eur J Surg Oncol; 2002 Mar 24; 28(2):120-5. PubMed ID: 11884046
    [Abstract] [Full Text] [Related]

  • 36. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
    Martin JH, Potthoff A, Ledig S, Cornberg M, Jandl O, Manns MP, Kubicka S, Flemming P, Athmann C, Beil W, Wagner S.
    Helicobacter; 2004 Oct 24; 9(5):371-86. PubMed ID: 15361075
    [Abstract] [Full Text] [Related]

  • 37. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells.
    Jiang S, Moriarty SE, Grossniklaus H, Nelson KC, Jones DP, Sternberg P.
    Invest Ophthalmol Vis Sci; 2002 Aug 24; 43(8):2546-53. PubMed ID: 12147583
    [Abstract] [Full Text] [Related]

  • 38. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE, Shanahan F, O'Connell J, Houston AM.
    Cancer Res; 2005 Nov 01; 65(21):9817-23. PubMed ID: 16267003
    [Abstract] [Full Text] [Related]

  • 39. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    Pérez EC, Shulzhenko N, Morgun A, Diniz RV, Almeida DR, Musatti CC, Gerbase-DeLima M.
    Hum Immunol; 2006 Nov 01; 67(1-2):22-6. PubMed ID: 16698421
    [Abstract] [Full Text] [Related]

  • 40. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A, Takagi A, Horibe S, Takagi H, Tamaya T.
    J Clin Endocrinol Metab; 1998 Feb 01; 83(2):427-31. PubMed ID: 9467552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.